Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Post Market Study of Patients With Symptomatic Benign Prostatic Hyperplasia Treated by Prostatic Artery Embolization With Embosphere® Microspheres

NCT03527589 is registered in ClinicalTrials.gov with Merit Medical Systems, Inc. as lead sponsor.

NCT NCT03527589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03527589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Post Market Study of Patients With Symptomatic Benign Prostatic Hyperplasia Treated by Prostatic Artery Embolization With Embosphere® Microspheres
Lead sponsor
Merit Medical Systems, Inc.
Phase
Observational
Overall status
Completed
Start date
August 16, 2018
Completion date
January 22, 2022
Enrollment
499 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, lower urinary tract symptoms